|
|
|
|
 Dr Roger Bossé,
Sales Development Leader BioDiscovery PerkinElmer, Canada Roger Bossé holds a Ph.D. in Pharmacology from the University of Sherbrooke (Quebec, Canada). He completed his Post Doctoral training in Neuroendocrinology in Marc Caron’s lab (Cell Biology, Duke University, NC).
Dr. Bossé joined BioSignal in 1996 as the R&D Group Leader responsible for the development of the GPCR pipeline. Following the acquisition of BioSignal by Packard in 1998, he was promoted Associated Director R&D and his team developed the AlphaScreen product line. After the merger between PerkinElmer and Packard BioSciences in 2001, Dr. Bossé and his team initiated the development of the AlphaLISA platform. In 2006, he transitioned to new functions in Business and Sales development.
Dr. Bossé co-organized the 13th SBS annual meeting in Montreal in 2007. He was elected on the SBS board of directors in 2008. He also created a new Special Interest Group (SIG) on Drug repositioning within SBS.
Appearing: Conference Day One: Wednesday, 17 March 2010 11.35 PerkinElmer Solutions for Drug Discovery: from Target Identification/ Validation to Biologics Development Dr Roger Bossé, Sales Development Leader BioDiscovery,
PerkinElmer, Canada |
|
|
|
|
|
Session sponsor:
Exhibitors:
|
asia research institution poster presentation
* For first 20 confirmed poster presentations
|
|
|
|
|
|
|
|
|
